ATAI Life Sciences NV (FRA:9VC) Scaled Net Operating Assets : 0.38 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is ATAI Life Sciences NV Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ATAI Life Sciences NV's operating assets for the quarter that ended in Sep. 2024 was €100.55 Mil. ATAI Life Sciences NV's operating liabilities for the quarter that ended in Sep. 2024 was €24.68 Mil. ATAI Life Sciences NV's Total Assets for the quarter that ended in Jun. 2024 was €200.46 Mil. Therefore, ATAI Life Sciences NV's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.38.

ATAI Life Sciences NV Scaled Net Operating Assets Historical Data

The historical data trend for ATAI Life Sciences NV's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Scaled Net Operating Assets Chart

ATAI Life Sciences NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.48

0.24

0.02

0.27

ATAI Life Sciences NV Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.31	0.27	0.47	0.38	0.38

Competitive Comparison of ATAI Life Sciences NV's Scaled Net Operating Assets

For the Biotechnology subindustry, ATAI Life Sciences NV's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ATAI Life Sciences NV's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ATAI Life Sciences NV's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where ATAI Life Sciences NV's Scaled Net Operating Assets falls into.

ATAI Life Sciences NV Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ATAI Life Sciences NV's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(104.74	-	27.529)	/	288.336
=	0.27

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	269.119	-	164.379
=	104.74

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	45.082	-	17.301	-	0.252
=	27.529

ATAI Life Sciences NV's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Jun. 2024 )
=	(100.551	-	24.684)	/	200.458
=	0.38

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	177.965	-	77.414
=	100.551

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	46.134	-	19.051	-	2.399
=	24.684

ATAI Life Sciences NV Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of ATAI Life Sciences NV's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ATAI Life Sciences NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (FRA:9VC) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

ATAI:USA ATAI:Mexico

Address

Wallstrasse 16, Berlin, BB, DEU, 10179

Website

https://www.atai.life

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV Headlines

No Headlines